Evidence Based Medications in a Recovery Oriented Systems of Care

Dr. Launette Rieb, Dr. Rob Tanguay, Dr. Meldon Kahan

April 13th 2022 11:30 am Neilson Room 1

Session Description

Medications for Opioid Use Disorder are the Gold Standard and First-Line for treatment initiation. National guidelines do not support detoxification “without immediate transition to long term addiction treatment”. The panel will review buprenorphine-naloxone, the preferred option, followed by methadone and other alternatives, as well as review the possible harms from current practices in Canada such as the practice of safe supply. The practice of Addiction Medicine will be discussed along with common misconceptions about OAT including initiation, maintenance, and tapering.

Learning Objectives:

1.     Participants will be able to apply evidence-based treatments to Opioid Use Disorder. 

2.     After critically reviewing the literature participants will reflect and evaluate on their current practice.

3.     Participants will be able to implement protocols based on current evidence and best practice.


Launette Marie Rieb, MD, MSc, CCFP(AM), FCFP, DABAM, CCSAM, FASAM

Dr. Rieb is a Family Physician, Addiction Medicine Specialist, and Clinical Associate Professor at the University of British Columbia (UBC). She was the co-creator and initial Physician Director of what is now called the BCCSU Addiction Medicine Fellowship, and contributed to the formation of BC’s first Pain Medicine Fellowship. She works and does research in the areas of pain and addiction, serving clinical populations through ActumHealth, The Orchard Recovery Centre, and St. Paul’s Hospital. Dr. Rieb is the recipient of a UBC Post Graduate Teaching Award and the BC College of Family Physicians Exceptional Teacher Honour.

Dr. Meldon Kahan

Dr Kahan has worked in the addiction field for many years.  He is currently Medical Director of the METAPHI program in Ontario.  METAPHI (Mentoring, Education, and Tools for Addiction: Partners in Health Integration) provides oversight and education for the province’s sixty-five RAAM (Rapid Access to Addiction Medicine) clinics.  Dr Kahan is also the Medical Director of the Substance Use Service at Women’s College Hospital.

Dr Kahan has written a number of peer reviewed articles on addiction, and has been a principal or co-principal investigator on various research studies, including several randomized trials and observational studies.  He has been extensively involved in policy and advocacy. He has helped write several guidelines on opioid agonist treatment and opioid prescribing for chronic pain, and has co-authored several handbooks and guidance documents on addiction medicine.  He has given numerous presentations for local, provincial and national conferences.  His main interest is the integration of addiction medicine into primary care, EDs and hospitals.

Dr. Robert L. Tanguay

  • BSc (Hons), MD, FRCPC, CISAM, CCSAM 
  • Chief Medical Officer, The Newly Institute
  • Clinical Assistant Professor, University of Calgary 
  • Departments of Psychiatry and Surgery
  • President, Pain Society of Alberta
  • Alberta and NWT Regional Director, CSAM
  • Co-Lead, Alberta Pain Strategy, AHS
  • Founder and Clinic Lead, Opioid Deprescribing Program, AHS
  • Co-Founder and Co-Lead, Community RAAM, AHS
  • Hotchkiss Brain Institute & Mathison Centre for Mental Health

Dr. Tanguay is a Psychiatrist who completed two fellowships, one in Addiction Medicine and one in Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary.

Most recently Dr. Tanguay helped found and is the Chief Medical Officer and Vice President of The Newly Institute, a program dedicated to providing medical and psychological intervention for people living with complex and treatment-resistant mental health disorders such as PTSD, depression, anxiety, addiction, and chronic pain including access to psychedelic-assisted psychotherapy. He is the former Medical Lead for the Alberta Addiction Education Sessions for Alberta Health Services (AHS). He is the Regional Director for Alberta and North West Territories for the Canadian Society of Addiction Medicine (CSAM) where he sits as a board member, the President of the Pain Society of Alberta, and the co-chair of the internationally recognized Alberta Pain Strategy.  He is the founder of the Opioid Deprescribing Program with AHS, the Rapid Access Addiction Medicine (RAAM) Community Clinic with AHS, and the Transitional Outpatient Pain Program for Spine (TOPPS) clinic working with spinal surgeons to optimize spinal surgery outcomes.

Academically, he is involved in research in trauma, addiction, chronic pain, opioids, cannabis, and psychedelics and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.